María-Victoria Mateos, MD, PhD - Updates in Multiple Myeloma From Madrid: Data Surrounding BCMA-Directed Agents and Their Clinical Relevance

Visit https://www.peervoice.com/HEG860 to view the entire programme with slides. After completing “María-Victoria Mateos, MD, PhD - Updates in Multiple Myeloma From Madrid: Data Surrounding BCMA-Directed Agents and Their Clinical Relevance”, participants will be able to: Recall safety and efficacy data from clinical trials evaluating BCMA-directed therapies for the management of relapsed/refractory multiple myeloma; and Assess the potential clinical impact of these data, including patient populations included in trials and how these relate to real-world patients.